3 Key Trends Shaping Our Industry: Contract Pharma Thought Leadership Feature with Eleanor Row
Quotient Sciences’ Executive Director of Commercial, Eleanor Row, offers her thought leadership in Contract Pharma on the 3 key trends shaping our industry.
Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals and Quotient Sciences announce a partnership to support Crinetics’ CRN04894 pediatric program.
Dr. Dolly Jacob: Solubility & Bioavailability
Dr. Dolly Jacob, Director of Integrated Development Services at Quotient Sciences featured in Drug Development & Delivery looking at the challenges of solubility & bioavailability.
Dr. Vanessa Zann: Pharmaceutical Technology Contribution
Dr. Vanessa Zann, Senior Drug Development Consultant at Quotient Sciences featured in Pharmaceutical Technology looking at the important role of early-phase biopharmaceutics.
Quotient Sciences Contributes to Clinical Pharmacology in Drug Development article, "A Phase 1 Study of Savolitinib"
Quotient Sciences experts contribute to a recent article in the American College of Clinical Pharmacology® Clinical Pharmacology in Drug Development journal that highlights the results of an ADME study of AstraZeneca's savolitinib.